College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX, United States.
College of Engineering, University of Texas at Arlington, Arlington, TX, United States.
JMIR Res Protoc. 2024 Apr 29;13:e57878. doi: 10.2196/57878.
BACKGROUND: Preventable harms from medications are significant threats to patient safety in community settings, especially among ambulatory older adults on multiple prescription medications. Patients may partner with primary care professionals by taking on active roles in decisions, learning the basics of medication self-management, and working with community resources. OBJECTIVE: This study aims to assess the impact of a set of patient partnership tools that redesign primary care encounters to encourage and empower patients to make more effective use of those encounters to improve medication safety. METHODS: The study is a nonrandomized, cross-sectional stepped wedge cluster-controlled trial with 1 private family medicine clinic and 2 public safety-net primary care clinics each composing their own cluster. There are 2 intervention sequences with 1 cluster per sequence and 1 control sequence with 1 cluster. Cross-sectional surveys will be taken immediately at the conclusion of visits to the clinics during 6 time periods of 6 weeks each, with a transition period of no data collection during intervention implementation. The number of visits to be surveyed will vary by period and cluster. We plan to recruit patients and professionals for surveys during 405 visits. In the experimental periods, visits will be conducted with two partnership tools and associated clinic process changes: (1) a 1-page visit preparation guide given to relevant patients by clinic staff before seeing the provider, with the intention to improve communication and shared decision-making, and (2) a library of short educational videos that clinic staff encourage patients to watch on medication safety. In the control periods, visits will be conducted with usual care. The primary outcome will be patients' self-efficacy in medication use. The secondary outcomes are medication-related issues such as duplicate therapies identified by primary care providers and assessment of collaborative work during visits. RESULTS: The study was funded in September 2019. Data collection started in April 2023 and ended in December 2023. Data was collected for 405 primary care encounters during that period. As of February 15, 2024, initial descriptive statistics were calculated. Full data analysis is expected to be completed and published in the summer of 2024. CONCLUSIONS: This study will assess the impact of patient partnership tools and associated process changes in primary care on medication use self-efficacy and medication-related issues. The study is powered to identify types of patients who may benefit most from patient engagement tools in primary care visits. TRIAL REGISTRATION: ClinicalTrials.gov NCT05880368; https://clinicaltrials.gov/study/NCT05880368. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/57878.
背景:可预防的药物伤害对社区环境中的患者安全构成重大威胁,尤其是在服用多种处方药的门诊老年患者中。患者可以通过在决策中发挥积极作用、学习药物自我管理的基础知识以及与社区资源合作,与初级保健专业人员合作。 目的:本研究旨在评估一套患者合作工具的影响,这些工具重新设计了初级保健就诊,以鼓励和授权患者更有效地利用这些就诊来提高药物安全性。 方法:该研究是一项非随机、横断面、递进楔形群对照试验,包括 1 家私人家庭医学诊所和 2 家公共初级保健诊所,每个诊所组成自己的群组。有 2 个干预序列,每个序列 1 个群组,1 个对照序列 1 个群组。在 6 个 6 周的时间段内,每个诊所的就诊结束时将立即进行横断面调查,在干预实施期间将有一个不收集数据的过渡阶段。每个时间段和群组的调查访问量将有所不同。我们计划在 405 次就诊期间招募患者和专业人员进行调查。在实验期间,就诊将使用两种合作工具和相关的诊所流程变更进行:(1)诊所工作人员在患者就诊前给相关患者的 1 页就诊准备指南,旨在改善沟通和共同决策,(2) 一个关于药物安全的简短教育视频库,鼓励患者观看。在对照期间,就诊将采用常规护理。主要结果将是患者在药物使用方面的自我效能感。次要结果是由初级保健提供者确定的药物相关问题,例如双重治疗,以及评估就诊期间的协作工作。 结果:该研究于 2019 年 9 月获得资金。数据收集于 2023 年 4 月开始,并于 2023 年 12 月结束。在此期间共收集了 405 次初级保健就诊数据。截至 2024 年 2 月 15 日,已计算出初步描述性统计数据。预计将于 2024 年夏季完成并公布完整的数据分析。 结论:本研究将评估初级保健中患者合作工具和相关流程变更对药物使用自我效能感和药物相关问题的影响。该研究有足够的能力确定从初级保健就诊中受益最大的患者群体。 试验注册:ClinicalTrials.gov NCT05880368;https://clinicaltrials.gov/study/NCT05880368。 国际注册报告标识符(IRRID):DERR1-10.2196/57878。
Cochrane Database Syst Rev. 2022-2-1
Early Hum Dev. 2020-11
Ergonomics. 2024-1
J Am Board Fam Med. 2022